SLC5A2 and Glycosuria: Genetic knockout of SGLT2 resulted in increased urine flow and glucosuria without affecting the glomerular filtration rate (GFR) in mice9, and chronic treatment with an SGLT2 inhibitor showed sustained increases in urinary glucose excretion in wild-type mice10.